The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of germ-line SNPs with overall survival (OS) in pazopanib-treated patients (Pts) with advanced renal cell carcinoma (RCC).
C. Xu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
N. Bing
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
H. A. Ball
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
C. N. Sternberg
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
I. D. Davis
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Z. Xue
Employment or Leadership Position - GlaxoSmithKline
Honoraria - GlaxoSmithKline
L. McCann
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
K. King
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
J. C. Whittaker
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
C. F. Spraggs
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
V. E. Mooser
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
L. N. Pandite
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline